Research graph
References from Elucidation of the Mechanisms and Molecular Targets of Shuanglian Decoction for the Treatment of Hepatocellular Carcinoma Based on Network Pharmacology. Local targets link to admitted publications; unresolved targets remain external evidence.
Global cancer statistics, 2012
10.3322/caac.20107 · 2011 · External reference
Cancer statistics in China, 2015
10.3322/caac.21338 · 2016 · External reference
The evolving epidemiology of hepatocellular carcinoma: a global perspective
10.1586/17474124.2015.1028363 · 2015 · External reference
Progress on prevention and treatment of Chinese medicine to molecular mechanism of liver cancer
2009 · External reference
Different concentrations of Sijunzi decoction inhibit proliferation and induce apoptosis of human gastric cancer SGC-7901 side population
10.21010/ajtcam.v13i4.19 · 2016 · External reference
Effect of Sijunzi decoction(SJ) on Hepatoma-22 metastasis in mice
2010 · External reference
Effects of Xiaochaihu decoction containing drug serum on HepG-2 cell
2013 · External reference
The herbal mixture Xiao-Chai-Hu Tang (XCHT) induces apoptosis of human hepatocellular carcinoma Huh7 cells in vitro and in vivo
10.21010/ajtcam.v14i3.25 · 2017 · External reference
Prescription form of Strengthening Qi and Clearing Stasis and Poison effect on HepG2 liver cancer cell proliferation and the influence of the nude mouse transplantation tumor growth
2014 · External reference
Chemical constituents and pharmacological effects of Scutellaria barbata
2004 · External reference
Research progress on chemical constituents and pharmacological effects of Pulsatilla chinensis (Bunge) Rege
2016 · External reference
Ideas and methods on material basis of chemprevention of Prunella vulgaris on lung cancer
2009 · External reference
Caffeine metabolism in a group of 67 patients with primary biliary cirrhosis
10.5414/cpp39025 · 2001 · External reference
Network pharmacology-based study on the mechanism of Bushen-Jianpi decoction in liver cancer treatment
10.1155/2019/3242989 · 2019 · External reference
CytoNCA: A cytoscape plugin for centrality analysis and evaluation of protein interaction networks
10.1016/j.biosystems.2014.11.005 · 2015 · External reference
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
10.1038/nprot.2008.211 · 2009 · External reference
Protein-protein interaction detection: methods and analysis
10.1155/2014/147648 · 2014 · External reference
Lieber, Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968-1998)–a review
1999 · External reference
A novel method for evaluating the cardiotoxicity of traditional Chinese medicine compatibility by using support vector machine model combined with metabonomics
10.1155/2016/6012761 · 2016 · External reference
Health effects of quercetin: From antioxidant to nutraceutical
10.1016/j.ejphar.2008.03.008 · 2008 · External reference
Investigation of quercetin-induced HepG2 cell apoptosis-associated cellular biophysical alterations by atomic force microscopy
10.1002/sca.21245 · 2016 · External reference
Kaempferol protects against propacetamol-induced acute liver injury through CYP2E1 inactivation, UGT1A1 activation, and attenuation of oxidative stress, inflammation and apoptosis in mice
10.1016/j.toxlet.2018.03.024 · 2018 · External reference
Distribution and biological activities of the flavonoid luteolin
10.2174/138955709787001712 · 2009 · External reference
Review in pharmacological study of Baicalein
2001 · External reference
Research progress on free radicals in human body
2016 · External reference
Secondary prevention of recurrence by interferon therapy after ablation therapy for hepatocellular carcinoma in chronic hepatitis C patients
10.3748/wjg.14.6140 · 2008 · External reference
CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer
10.1002/ijc.10937 · 2003 · External reference
Promoting apoptosis as a strategy for cancer drug discovery
10.1038/nrc1736 · 2005 · External reference
Deciphering p53 signaling in tumor suppression
10.1016/j.ceb.2017.11.005 · 2018 · External reference
Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer
10.1158/1078-0432.ccr-06-2351 · 2007 · External reference
Clinicopathologic significance of HIF-1α, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer
10.1186/1471-2407-8-123 · 2008 · External reference
HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model
10.3892/ijo.2017.4058 · 2017 · External reference
Cancer-related inflammation
10.1038/nature07205 · 2008 · External reference
The complexity of NF-κB signaling in inflammation and cancer
10.1186/1476-4598-12-86 · 2013 · External reference
MCL plays an anti-inflammatory role in Mycobacterium tuberculosis-induced immune response by inhibiting NF-κB and NLRP3 inflammasome activation
10.1155/2017/2432904 · 2017 · External reference
Quercetin modulates NF-κ B and AP-1/JNK pathways to induce cell death in human hepatoma cells
10.1080/01635580903441196 · 2010 · External reference
Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma
10.18632/oncotarget.9437 · 2016 · External reference
The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors
10.1097/00008571-200208000-00008 · 2002 · External reference
CYP genes in osteosarcoma: Their role in tumorigenesis, pulmonary metastatic microenvironment and treatment response
10.18632/oncotarget.15869 · 2017 · External reference
Cytochrome P450 1A2 metabolizes 17β-estradiol to suppress hepatocellular carcinoma
10.1371/journal.pone.0153863 · 2016 · External reference
Phenotype breath tests as companion diagnostic tests (CDx) in clinical trials of drugs
10.4172/2153-0645.1000e106 · 2012 · External reference
Association of caffeine intake and CYP1A2 genotype with ovarian cancer
10.1207/s15327914nc4601_03 · 2003 · External reference
Hepatic CYP1A2 activity in liver tumors and the implications for preoperative volume-function analysis
2019 · External reference
CYP1A2 is a predictor of HCC recurrence in HCV-related chronic liver disease: A retrospective multicentric validation study
10.1016/j.dld.2016.12.002 · 2017 · External reference
